The Waiting May Be The Hard Part For Rigel Pharmaceuticals Seeking Alpha Further back, the company has a small collection of drugs for transplant rejection, dry eye, and various muscle ailments. The company also recently formed another partnership with AstraZeneca to cover R256 - a preclinical JAK inhibitor for asthma. I'm ... |
